Albert Pan
About Albert Pan
Albert Pan is the Chief Technology Officer with over 20 years of experience in molecular simulation for scientific research and drug discovery, previously serving as a Senior Research Scientist at D.E. Shaw Research.
Chief Technology Officer
Albert Pan serves as the Chief Technology Officer, bringing a wealth of expertise to the role. His extensive background spans over 20 years, during which he has focused on applying molecular simulation to address key scientific queries and facilitate drug discovery. In this capacity, he leverages his deep understanding of computational chemistry to drive technological advancements and improve research methodologies.
Molecular Simulation and Drug Discovery Expertise
Albert Pan has dedicated over two decades to the field of molecular simulation, contributing significantly to both fundamental science and the advancement of drug discovery. His work has centered around the development and implementation of computational techniques that enable detailed exploration of molecular interactions and behaviors. His expertise in free energy calculations and enhanced sampling methods highlights his ability to innovate and improve upon traditional research practices.
Senior Research Scientist at D.E. Shaw Research
Albert Pan spent more than 12 years as a Senior Research Scientist at D.E. Shaw Research. During his tenure, he was instrumental in leading projects focused on free energy calculations and the development of novel enhanced sampling methods. His contributions in these areas have had a significant impact on the field of biophysics, reinforcing his reputation as a leader in computational chemistry.
Educational Background in Chemistry and Physics
Albert Pan holds a Ph.D. in Chemistry from the University of California, Berkeley. Additionally, he earned an A.B. in Chemistry and Physics from Harvard University, graduating magna cum laude. His educational background laid a solid foundation for his career in scientific research and technology. Furthermore, he expanded his expertise during his time as an NIH NRSA Postdoctoral Fellow at the University of Chicago, where he continued to delve into complex scientific questions and methodologies.